Centre for Molecular Nanometrology, Department of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD, UK.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, G1 1XQ, UK.
Analyst. 2023 May 30;148(11):2594-2608. doi: 10.1039/d3an00121k.
Radiation therapy is currently utilised in the treatment of approximately 50% of cancer patients. A move towards patient tailored radiation therapy would help to improve the treatment outcome for patients as the inter-patient and intra-patient heterogeneity of cancer leads to large differences in treatment responses. In radiation therapy, a typical treatment outcome is cell cycle arrest which leads to cell cycle synchronisation. As treatment is typically given over multiple fractions it is important to understand how variation in the cell cycle can affect treatment response. Raman spectroscopy has previously been assessed as a method for monitoring radiation response in cancer cells and has shown promise in detecting the subtle biochemical changes following radiation exposure. This study evaluated Raman spectroscopy as a potential tool for monitoring cellular response to radiation in synchronised unsynchronised UVW human glioma cells . Specifically, it was hypothesised that the UVW cells would demonstrate a greater radiation resistance if the cell cycle phase of the cells was synchronised to the G/S boundary prior to radiation exposure. Here we evaluated whether Raman spectroscopy, combined with cell cycle analysis and DNA damage and repair analysis (γ-H2AX assay), could discriminate the subtle cellular changes associated with radiation response. Raman spectroscopy combined with principal component analysis (PCA) was able to show the changes in radiation response over 24 hours following radiation exposure. Spectral changes were assigned to variations in protein, specifically changes in protein signals from amides as well as changes in lipid expression. A different response was observed between cells synchronised in the cell cycle and unsynchronised cells. After 24 hours following irradiation, the unsynchronised cells showed greater spectral changes compared to the synchronised cells demonstrating that the cell cycle plays an important role in the radiation resistance or sensitivity of the UVW cells, and that radiation resistance could be induced by controlling the cell cycle. One of the main aims of cancer treatment is to stop the proliferation of cells by controlling or halting progression through the cell cycle, thereby highlighting the importance of controlling the cell cycle when studying the effects of cancer treatments such as radiation therapy. Raman spectroscopy has been shown to be a useful tool for evaluating the changes in radiation response when the cell cycle phase is controlled and therefore highlighting its potential for assessing radiation response and resistance.
放射治疗目前用于约 50%的癌症患者的治疗。朝着个体化治疗的方向发展将有助于改善患者的治疗效果,因为癌症患者之间和患者内部的异质性导致治疗反应存在很大差异。在放射治疗中,典型的治疗结果是细胞周期停滞,导致细胞周期同步。由于治疗通常分为多个部分进行,因此了解细胞周期的变化如何影响治疗反应非常重要。拉曼光谱已被评估为监测癌细胞放射反应的一种方法,并且在检测放射暴露后微妙的生化变化方面显示出了前景。本研究评估了拉曼光谱作为监测同步和未同步 UVW 人神经胶质瘤细胞对辐射的细胞反应的潜在工具。具体而言,假设如果在放射暴露之前将细胞的细胞周期阶段同步到 G/S 边界,则 UVW 细胞将表现出更大的辐射抗性。在这里,我们评估了拉曼光谱是否结合细胞周期分析和 DNA 损伤和修复分析(γ-H2AX 测定),能否区分与放射反应相关的微妙细胞变化。拉曼光谱与主成分分析(PCA)相结合,能够显示出放射暴露后 24 小时内放射反应的变化。光谱变化归因于蛋白质的变化,特别是酰胺的蛋白质信号变化以及脂质表达的变化。在细胞周期同步和未同步细胞之间观察到不同的反应。照射后 24 小时,未同步的细胞显示出比同步的细胞更大的光谱变化,这表明细胞周期在 UVW 细胞的辐射抗性或敏感性中起着重要作用,并且可以通过控制细胞周期来诱导辐射抗性。癌症治疗的主要目标之一是通过控制或阻止细胞周期的进展来阻止细胞的增殖,从而突出了在研究癌症治疗(如放射治疗)的影响时控制细胞周期的重要性。已经表明,当控制细胞周期时,拉曼光谱是评估放射反应变化的有用工具,因此突出了其评估放射反应和抗性的潜力。